185 related articles for article (PubMed ID: 16556409)
1. [The value of serum markers in evaluating liver fibrotic changes].
Hu YY; Liu P; Liu C; Liu CH; Xu LM
Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):174-7. PubMed ID: 16556409
[TBL] [Abstract][Full Text] [Related]
2. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
[TBL] [Abstract][Full Text] [Related]
3. [Study on the influence factors of the serum fibrosis markers].
Cai WM; Tao J; Weng HL; Liu RH
Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):23-5. PubMed ID: 12546736
[TBL] [Abstract][Full Text] [Related]
4. [Supplemental Fuzhenghuayu capsule therapy for improving liver fibrosis markers in patients with chronic hepatitis B following unsatisfactory outcome of nucleos(t)ide analogue monotherapy].
Tian YL; Zhu XY; Yin WW; Zang ZD; Wang L; Fu XL
Zhonghua Gan Zang Bing Za Zhi; 2013 Jul; 21(7):514-8. PubMed ID: 24074710
[TBL] [Abstract][Full Text] [Related]
5. [Investigation on indication of fuzheng huayu capsule against hepatic fibrosis and its non-invasive efficacy evaluation parameters: data analysis of liver biopsy of 50 patients with chronic hepatitis B before and after treatment].
Hu YY; Liu P; Liu C
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan; 26(1):18-22. PubMed ID: 16466166
[TBL] [Abstract][Full Text] [Related]
6. [Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B].
Liu P; Hu YY; Liu C; Xu LM; Liu CH; Sun KW; Hu DC; Yin YK; Zhou XQ; Wan MB; Cai X; Zhang ZQ; Ye J; Tang BZ; He J
Zhong Xi Yi Jie He Xue Bao; 2003 Jul; 1(2):89-98, 102. PubMed ID: 15339577
[TBL] [Abstract][Full Text] [Related]
7. Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B.
Liu P; Hu YY; Liu C; Xu LM; Liu CH; Sun KW; Hu DC; Yin YK; Zhou XQ; Wan MB; Cai X; Zhang ZQ; Ye J; Zhou RX; He J; Tang BZ
World J Gastroenterol; 2005 May; 11(19):2892-9. PubMed ID: 15902724
[TBL] [Abstract][Full Text] [Related]
8. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
Kozłowska J; Łoch T; Jabłońska J; Cianciara J
Przegl Epidemiol; 2001; 55(4):451-8. PubMed ID: 11921731
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of serum biochemical markers for liver fibrosis in patients with hepatitis B virus].
Huang W; Gong FY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):1034-6. PubMed ID: 12433643
[TBL] [Abstract][Full Text] [Related]
10. Assessing routine and serum markers of liver fibrosis in CHB patients using parallel and serial interpretation.
Hongbo L; Xiaohui L; Hong K; Wei W; Yong Z
Clin Biochem; 2007 May; 40(8):562-6. PubMed ID: 17362902
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of serum glutamyl transpeptidase in chronic hepatitis B].
Xian YC; Yang JY; Xu R; Huang CJ; Wu LL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):383-5. PubMed ID: 18322611
[TBL] [Abstract][Full Text] [Related]
12. [The clinical study on decompensatory cirrhotic patients treated by Bie Jia Jian].
Wang YZ; Yang HZ; Lin BL; Xie HP; Li YW; Dai M
Zhong Yao Cai; 2007 Jun; 30(6):755-7. PubMed ID: 17918451
[TBL] [Abstract][Full Text] [Related]
13. [The clinical study on chronic hepatitis B treated by the four-step therapeutics of Traditional Chinese Medicine].
Yang HZ; Wang FL; Wang YZ; Shen WS; Xu GL; Yang YW; Huang XL
Zhong Yao Cai; 2006 Jul; 29(7):748-52. PubMed ID: 17059015
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of non-invasive indices for liver histology in patients with chronic hepatitis B].
Chen YP; Zhu YF; Feng XR; Peng J; Hou JL
Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1181-3. PubMed ID: 15485795
[TBL] [Abstract][Full Text] [Related]
15. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
[TBL] [Abstract][Full Text] [Related]
16. A study of the effect of splenectomy on hepatic functional reserve and structural damage in patients with chronic hepatitis C virus infection by non-invasive serum markers. A prospective study.
Elsebae MM; Abu-Zekri NB
Int J Surg; 2008 Oct; 6(5):362-6. PubMed ID: 18662898
[TBL] [Abstract][Full Text] [Related]
17. [The detection and clinical significance of hepatic fibrosis index].
Xu CH; Meng DM; Lv SL; Kang P
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):50-2. PubMed ID: 20848851
[TBL] [Abstract][Full Text] [Related]
18. [Serum gamma-glutamyl transpeptidase activity in children with chronic hepatitis B].
Lebensztejn DM; Skiba E; Sobaniec-Lotowska ME; Kaczmarski M
Pol Merkur Lekarski; 2005 Mar; 18(105):271-4. PubMed ID: 15997630
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
Parise ER; Oliveira AC; Figueiredo-Mendes C; Lanzoni V; Martins J; Nader H; Ferraz ML
Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
[TBL] [Abstract][Full Text] [Related]
20. [Effects of Kang Gang Qian Granule (KGQG) on clinical and pathological features in chronic hepatitis B patients].
Xiao HJ; Shi CG; Zhang AP; Li P; Fan ZS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):369-71. PubMed ID: 18322606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
